Arkolith/Insider Trading/STOK/Form 4

Kaye Edward M. MD

DirectorStoke Therapeutics, Inc. (STOK) · full profile →Form 4 · filed Dec 5, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$467K
Net Open-Market Flow
-$467K
Transactions
7
6 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 5, 2025Sell(S)6K$31.33$199K65K
Dec 5, 2025Sell(S)500$31.85$16K63K
Dec 5, 2025Sell(S)2K$31.15$52K63K
Dec 4, 2025Sell(S)5K$30.76$161K72K
Dec 4, 2025Sell(S)1K$31.32$39K71K
Dec 3, 2025Option exercise(M)26K—$078K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Dec 3, 2025Option exercise(M)26K—$00

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001522780-25-000009) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML